Description
An antibiotic that selectively inhibits cellular lipid biosynthesis (IC50 = 0.1 μM) by targeting FabF/B, an enzyme important for the biosynthesis of fatty acids; also inhibits mammalian fatty acid synthase, which reduces liver triglyceride levels and improves insulin sensitivity in a diabetic mouse model
Formal name: 3-[[3-[(1S,3S,4S,9S)-1,4,5,8,9,9aR-hexahydro-3,9-dimethyl-8-oxo-3H-1,4:3,5aS-dimethano-2-benzoxepin-9-yl]-1-oxopropyl]amino]-2,4-dihydroxy-benzoic acid
Synonyms: PTM
Molecular weight: 441.5
CAS: 835876-32-9
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Natural Products|Microbial Metabolites||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases